## **Core Concept**
Oral contraceptive pills (OCPs) can interact with various medications, affecting their efficacy or increasing the risk of adverse effects. The primary concern with OCPs and drug interactions is related to their metabolism and the potential for drug interactions that can alter their effectiveness or lead to toxicity.

## **Why the Correct Answer is Right**
The correct answer, **C. Rifampicin**, is a rifamycin antibiotic used to treat tuberculosis and certain other bacterial infections. Rifampicin is a potent enzyme inducer, particularly of the cytochrome P450 system, specifically inducing CYP3A4. This induction increases the metabolism of ethinyl estradiol and progestins found in OCPs, potentially reducing their plasma concentrations and efficacy, which can lead to contraceptive failure. Therefore, women on OCPs who are prescribed rifampicin need to consider alternative or additional contraceptive methods.

## **Why Each Wrong Option is Incorrect**
- **Option A:** There is no commonly recognized interaction between OCPs and drugs that would make A a correct answer in the context provided.
- **Option B:** While certain antiepileptic drugs can interact with OCPs, the specific concern with OCPs is more prominently associated with enzyme inducers like rifampicin rather than the broad category of antiepileptics.
- **Option D:** There is no well-documented interaction that would contraindicate OCPs with the drug in option D in the context provided.

## **Clinical Pearl / High-Yield Fact**
A key clinical pearl is that any medication which is an enzyme inducer (like rifampicin, phenytoin, and certain antiretrovirals) can potentially decrease the effectiveness of OCPs. Clinicians often advise patients on such medications to use an additional form of contraception to prevent unplanned pregnancies.

## **Correct Answer:** . Rifampicin